Philips buys China's No 2 in patient monitoring for Asian expansion:
This article was originally published in Clinica
In a move to broaden its presence in the Chinese healthcare market, Philips has acquired China's second largest patient monitoring company, Shenzhen Goldway Industrial. Goldway's range of FDA-cleared and CE-marked patient monitors helped the company grow its sales by 30% in 2007. The 290-strong company has a distribution network that serves mid- and large-sized hospitals throughout China, according to Philips. On completion of the transaction, which is expected in the second quarter of 2008, Goldway will become part of Philips Healthcare's patient monitoring division.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.